Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • March 2005 | Volume 18 - Issue 3
    Here one can see well-adhered ischemic eschar. The authors used conservative care including topical enzymatic agents until the eschar began to slough around the periphery.
    By Jonathan Moore, DPM, and Pamela Jensen, DPM
    38,274 reads | 0 comments | 09/03/08
       Diabetic heel ulcers constitute one of the most frustrating problems for podiatric physicians. Pressure ulcers affect nearly 2 million people each year and account for annual healthcare costs that range between $2.2 billion and $3.6 billion. The heel is the second leading site for development of pressure ulcers after the sacrum.1 While patients with diabetes are living longer than in the past, the incidence of hospital-acquired heel ulcers increased from 19 percent in 1989 to 30 percent in 1993.2    Costs for heel ulcers are nearly dou... continue reading
    Seventh in a series
    By Brian McCurdy, Associate Editor
    6,626 reads | 0 comments | 09/03/08
       The potential side effects of nonsteroidal antiinflammatory drugs (NSAIDs), including COX-2 inhibitors, have been well documented recently. The highly publicized Public Health Advisory from the Food and Drug Administration on celecoxib (Celebrex) and rofecoxib (Vioxx) has increased the discussion about the safety of such agents. What types of side effects should one be wary of with NSAIDs and COX-2 inhibitors, and what screening precautions can one take?    Nicholas Grumbine, DPM, has seen gastrointestinal (GI) difficulties and bleeding in patients taking ... continue reading
    By Jeff Hall, Executive Editor
    2,097 reads | 0 comments | 09/03/08
       Over 18 percent of people age 60 and over in the United States have diabetes. According to the American Diabetes Association, 1.3 million new cases of diabetes are diagnosed every year in people over the age of 20. Between 60 to 70 percent of people with diabetes have mild to severe forms of nervous system damage, a major contributing factor to lower-extremity amputation. Greater than 60 percent of nontraumatic lower-limb amputations in the U.S. occur among patients with diabetes.    With these statistics in mind, we present our Fifth Annual Diabetes theme ... continue reading
    Here one can see a medial capsular incision from the dorsal medial aspect of the proximal portion of the metatarsal head.
    By Richard O. Lundeen, DPM
    14,413 reads | 0 comments | 09/03/08
       Back when I left the didactic world of podiatry school and entered my residency, I was ready for a transition that would blend the books with practice. Of course, the first two surgeries I performed did not fit the mold. The first one was a cartilage articulation preservation procedure (CAPP) and the other was a Keller procedure.    The CAPP procedure was familiar to me only in books and the Keller seemed “outdated.” To my surprise, both surgeries turned out well and gave me an appreciation that diverse types of procedures can have a good outcome when t... continue reading